Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inherited or acquired disorder of electrolyte metabolism, characterized by the inability of the renal tubules to respond to aldosterone. It is manifested by hyperkalemic metabolic acidosis, urinary salt wasting, normal or increased aldosterone secretion and normal glomerular filtration rate.
Biomarker and diagnostic research for pseudohypoaldosteronism has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
63 publications have been identified in PubMed for pseudohypoaldosteronism. Research spans Case Report / Case Series (65%), Review / Meta-Analysis (17%), and Epidemiology / Natural History (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 41 | 65% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
11 |
17% |
Disease patterns and progression | 5 | 8% |
Laboratory research | 4 | 6% |
Testing and diagnosis research | 2 | 3% |
Kanai H (2026). [PMID: 41841078](https://pubmed.ncbi.nlm.nih.gov/41841078/). *Cureus*. [Case Report / Case Series]
Wu Z (2026). [PMID: 41982973](https://pubmed.ncbi.nlm.nih.gov/41982973/). *Transl Pediatr*. [Case Report / Case Series]
Martinerie L (2026). [PMID: 41543024](https://pubmed.ncbi.nlm.nih.gov/41543024/). *J Endocrinol*. [Review / Meta-Analysis]
Bolaç Özyılmaz LG (2026). [PMID: 41275343](https://pubmed.ncbi.nlm.nih.gov/41275343/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Alquraishi A (2026). [PMID: 42077744](https://pubmed.ncbi.nlm.nih.gov/42077744/). *Cureus*. [Case Report / Case Series]
Cay M (2026). [PMID: 41380172](https://pubmed.ncbi.nlm.nih.gov/41380172/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Ma H (2026). [PMID: 42146936](https://pubmed.ncbi.nlm.nih.gov/42146936/). *Front Pediatr*. [Case Report / Case Series]
Calviño-Costas M (2026). [PMID: 40975704](https://pubmed.ncbi.nlm.nih.gov/40975704/). *Med Intensiva (Engl Ed)*. [Case Report / Case Series]
Kuchay MS (2026). [PMID: 42057493](https://pubmed.ncbi.nlm.nih.gov/42057493/). *Nephrology (Carlton)*. [Case Report / Case Series]
Bahadoran E (2026). [PMID: 41522852](https://pubmed.ncbi.nlm.nih.gov/41522852/). *Clin Case Rep*. [Case Report / Case Series]